Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands.

Robert Gerald Jan MoesEline L HuismanSamuel J P MalkinBarnaby Hunt

Published in: ClinicoEconomics and outcomes research : CEOR (2023)

The clinical and economic burden of poor glycemic control in people with type 1 diabetes in the Netherlands was projected to be substantial, but considerable gains in quality-adjusted life expectancy and cost savings could be achieved through early and effective treatment.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
climate change
metabolic syndrome
skeletal muscle
combination therapy